341 related articles for article (PubMed ID: 17445182)
1. Influence of killer cell immunoglobulin-like receptor genotypes on acute graft-vs-host disease after unrelated hematopoietic stem cell transplantation in Koreans.
Kim SY; Choi HB; Yoon HY; Choi EJ; Cho B; Kim HK; Kim YJ; Kim HJ; Min CK; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
Tissue Antigens; 2007 Apr; 69 Suppl 1():114-7. PubMed ID: 17445182
[TBL] [Abstract][Full Text] [Related]
2. Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations.
Gagne K; Busson M; Balere-Appert ML; Absi L; Jollet I; Bignon JD; Bois M; Dormoy A; Dubois V; Gebuhrer L; Loiseau P; Masson D; Moine A; Perrier P; Reviron D; Charron D; Raffoux C;
Tissue Antigens; 2007 Apr; 69 Suppl 1():118-22. PubMed ID: 17445183
[TBL] [Abstract][Full Text] [Related]
3. The activating killer cell immunoglobulin-like receptors as important determinants of acute graft-versus host disease in hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Choi Y; Min WS; Kim TG; Cho BS; Kim SY; Eom KS; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Kim CC
Transplantation; 2007 Nov; 84(9):1082-91. PubMed ID: 17998861
[TBL] [Abstract][Full Text] [Related]
4. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.
Kröger N; Binder T; Zabelina T; Wolschke C; Schieder H; Renges H; Ayuk F; Dahlke J; Eiermann T; Zander A
Transplantation; 2006 Oct; 82(8):1024-30. PubMed ID: 17060849
[TBL] [Abstract][Full Text] [Related]
5. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
6. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
7. [Distribution of immunoglobulin like receptor gene in Han population in China and the impact thereof on the HLA-identical sibling hematopoietic stem cell transplantation].
Dou LP; DA WM; Zhao DD; Wang C; Lu XC; Kang HY; Yan P; Wang FF; Zhu HY; Li HH; Gao CJ; Yu L
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3111-4. PubMed ID: 18269867
[TBL] [Abstract][Full Text] [Related]
8. A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation.
Verheyden S; Schots R; Duquet W; Demanet C
Leukemia; 2005 Aug; 19(8):1446-51. PubMed ID: 15973456
[TBL] [Abstract][Full Text] [Related]
9. KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
Ludajic K; Balavarca Y; Bickeböller H; Rosenmayr A; Fae I; Fischer GF; Kouba M; Pohlreich D; Kalhs P; Greinix HT
Bone Marrow Transplant; 2009 Jul; 44(2):97-103. PubMed ID: 19169284
[TBL] [Abstract][Full Text] [Related]
10. Activating killer immunoglobulin-like receptor incompatibilities enhance graft-versus-host disease and affect survival after allogeneic hematopoietic stem cell transplantation.
Giebel S; Nowak I; Dziaczkowska J; Czerw T; Wojnar J; Krawczyk-Kulis M; Holowiecki J; Holowiecka-Goral A; Markiewicz M; Kopera M; Karolczyk A; Kyrcz-Krzemien S; Kusnierczyk P
Eur J Haematol; 2009 Oct; 83(4):343-56. PubMed ID: 19500138
[TBL] [Abstract][Full Text] [Related]
11. Killer-cell immunoglobulin-like receptor ligand compatibility in the outcome of Finnish unrelated donor hematopoietic stem cell transplantation.
Sivula J; Volin L; Porkka K; Vettenranta K; Itälä M; Partanen J; Turpeinen H
Transpl Immunol; 2007 Jul; 18(1):62-6. PubMed ID: 17584604
[TBL] [Abstract][Full Text] [Related]
12. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC; Gooley T; Malkki M; Pinto-Agnello C; Dupont B; Bignon JD; Bornhäuser M; Christiansen F; Gratwohl A; Morishima Y; Oudshoorn M; Ringden O; van Rood JJ; Petersdorf E;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
[TBL] [Abstract][Full Text] [Related]
13. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
[TBL] [Abstract][Full Text] [Related]
15. Role of killer immunoglobulin-like receptor-ligand interactions in human leukocyte antigen-matched sibling hematopoietic stem cell transplantation.
Kanga U; Mourya M; Seth T; George J; Sood P; Sharma R; Saxena A; Mehra NK
Transplant Proc; 2012 May; 44(4):919-21. PubMed ID: 22564585
[TBL] [Abstract][Full Text] [Related]
16. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
[TBL] [Abstract][Full Text] [Related]
17. Alloreactive killer cells: hindrance and help for haematopoietic transplants.
Parham P; McQueen KL
Nat Rev Immunol; 2003 Feb; 3(2):108-22. PubMed ID: 12563295
[TBL] [Abstract][Full Text] [Related]
18. Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation.
Giebel S; Nowak I; Wojnar J; Markiewicz M; Dziaczkowska J; Wylezol I; Krawczyk-Kulis M; Bloch R; Kusnierczyk P; Holowiecki J
Transplant Proc; 2006; 38(1):287-91. PubMed ID: 16504727
[TBL] [Abstract][Full Text] [Related]
19. Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML.
Sun JY; Gaidulis L; Dagis A; Palmer J; Rodriguez R; Miller MM; Forman SJ; Senitzer D
Bone Marrow Transplant; 2005 Sep; 36(6):525-30. PubMed ID: 16025153
[TBL] [Abstract][Full Text] [Related]
20. Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation.
Ruggeri L; Capanni M; Mancusi A; Urbani E; Perruccio K; Burchielli E; Tosti A; Topini F; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2004; 33(3):216-21. PubMed ID: 15528134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]